S100 proteins in Corpora Amylacea from normal human brain

Brain Research

Volumn 867, Issue 1-2, 2000, Pages 280-288

  Hoyaux, Daphné ^a   Decaestecker, Christine ^a   Heizmann, Claus W ^b   Vogl, Thomas ^c   Schäfer, Beat W ^b   Salmon, Isabelle ^a   Kiss, Robert ^a   Pochet, Roland ^a  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Aging; Calcium binding; Corpora amylacea; Human brain; Inflammation; Neurodegenerative disease; Polyglucosan bodies; S100

Indexed keywords

PROTEIN S 100; PROTEIN SUBUNIT;

AMYLOID BODY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN CELL; CELL AGING; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE ACTIVATION; MALE; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIBODY SPECIFICITY; FEMALE; HUMANS; INCLUSION BODIES; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PONS; REFERENCE VALUES; S100 PROTEINS;

EID: 0034625696     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02393-3     Document Type: Article

References (45)

1. Abe M., Umehara F., Kubota R., Moritoyo T., Izumo S., Osame M. Activation of macrophages/microglia with the calcium-binding protein MRP 14 and MRP 8 is related to the lesional activities in the spinal cord of HTLV-I associated myelopathy. J. Neurol. 246:1999;358-364.
2. Brück W., Porada P., Poser S., Rieckmann P., Hanefeld F., Kretzschmar H.A., Lassmann H. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann. Neurol. 38:1995;788-796.
3. Camby I., Nagy N., Lopes M-B., Schäfer B.W., Maurage C-A., Ruchoux M-M., Murmann P., Pochet R., Heizmann C.W., Brotchi J., Salmon I., Kiss R., Decaestecker C. Supratentorial pilocytic astrocytomas, astrocytomas, anaplasic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins. Brain Pathol. 9:1999;1-19.
4. Cavanagh J.B. Corpora-amylacea and the family of polyglucosan diseases. Brain Res. Brain Res. Rev. 29:1999;265-295.
5. Chung M.H., Horoupian D.S. Corpora amylacea: a marker for mesial temporal sclerosis. J. Neuropathol. Exp. Neurol. 55:1996;403-408.
6. Cissé S., Lacoste-Royal G., Laperrière J., Cabana T., Gauvreau D. Ubiquitin is a component of polypeptides purified from corpora amylacea of aged human brain. Neurochem. Res. 16:1991;429-433.
7. Cissé S., Perry G., Lacoste-Royal G., Cabana T., Gavreau D. Immunochemical identification of ubiquitin and heat-shock proteins in corpora amylacea from normal aged and Alzheimer's disease brains. Acta Neuropathol. (Berl.). 85:1993;233-240.
8. Donato R. Calcium-independent, pH-regulated effects of S-100 proteins on assembly-disassembly of brain microtubule protein in vitro. J. Biol. Chem. 263:1988;106-110.
9. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim. Biophys. Acta. 1450:1999;191-231.
10. Garbuglia M., Verzini M., Giambanco I., Spreca A., Donato R. Effects of calcium-binding proteins (S-100a(o), S-100a, S-100b) on desmin assembly in vitro. FASEB J. 10:1996;317-324.
11. 2+-dependent interaction of S100A2 with muscle and nonmuscle tropomyosins. J. Cell. Sci. 110:1997;611-621.
12. C.W. Heizmann, K. Braun, Calcium regulation by calcium-binding proteins in neurodegenerative disorders. Neuroscience Intelligence Unit. RC Landes Company, Austin, USA, and Springer Verlag, Heidelberg, Germany, 1995.
13. 2+-binding protein family. Biometals. 11:1998;383-397.
14. Herrick M.K., Twin J.L., Vladutiu G.D., Glasscock G.F., Horoupian D.S. Concomitant branching enzyme and phosphorylase deficiencies. An usual glycogenosis with extensive neuronal polyglucosan storage. J. Neuropathol. Exp. Neurol. 53:1994;239-246.
15. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M.F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., Schmidt A.M. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 97:1999;889-901.
16. 2+-binding proteins, S100A1, S100A2, S100A4, S100A6 and S100B in salivary gland tumors. J. Oral. Pathol. Med. 25:1996;547-555.
17. Ilg E.C., Schäfer B.W., Heizmann C.W. Expression pattern of S100 calcium-binding proteins in human tumors. Int. J. Cancer. 68:1996;325-332.
18. Inoue M., Yagishita S., Itoh Y., Amano N., Matsushita M. Coexistence of paired helical filaments and polyglucosan bodies in the same neuron in an autopsy case of Alzheimer's disease. Acta Neuropathol. (Berl.). 92:1996;511-514.
19. Iwaki T., Hamada Y., Tateishi J. Advanced glycation end-products and heat-shock proteins accumulate in the basophilic degeneration of the myocardium and the corpora amylacea of the glia. Pathol. Int. 46:1996;757-763.
20. Kawashima T., Adachi T., Tokunaga Y., Furuta A., Suzuki S.O., Doh-ura K., Iwaki T. Immunohistochemical analysis in a case of idiopathic Lennox-Gastaut syndrome. Clin. Neuropathol. 18:1999;286-292.
21. Kerkhoff C., Klempt M., Sorg C. Novel insights into structure and function of MRP 8 (S100A8) and MRP 14 (S100A9). Biochim. Biophys. Acta. 1448:1998;200-211.
22. ε-(carboxymethyl)lysine and pentosidine, in age-related inclusions in human brain. Pathol. Int. 48:1998;575-579.
23. Kriajevska M., Tarabykina S., Bronstein I., Maitland N., Lomonosov M., Hansen K., Georgiev G., Lukanidin E. Metastasis-associated Mts-1 (S100A4) protein modulates protein kinase C phosphorylation of the heavy chain of nonmuscle myosin. J. Biol. Chem. 273:1998;9852-9856.
24. Li Y., Wang J., Sheng J.G., Liu L., Barger S.W., Jones R.A., Van Eldik L.J., Mrak R.E., Griffin W.S.T. S100β increases levels of β-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. J. Neurochem. 71:1998;1421-1428.
25. Liu H.M., Anderson K., Caterson B. Demonstration of a keratin sulfate proteoglycan and a mannose-rich glycoconjugate in corpora amylacea of the brain by immunocytochemical and lectin-binding methods. J. Neuroimmunol. 14:1987;49-60.
26. Loeffler K.U., Edward D.P., Tso M.O.M. Tau-2 immunoreactivity of corpora amylacea in the human retina and optic nerve. Invest. Ophthalmol. Vis. Sci. 34:1993;2600-2603.
27. Mani R.S., McCubbin W.D., Kay C.M. Calcium-dependent regulation of caldesmon by an 11-kDa smooth muscle calcium-binding protein, caltropin. Biochemistry. 31:1992;11896-11901.
28. McDonald T.D., Faust P.L., Bruno C., DiMauro S., Goldman J.E. Polyglucosan body disease simulating amyotrophic lateral sclerosis. Neurology. 43:1993;785-790.
29. Mizutani T., Satoh J., Morimatsu Y. Axonal polyglucosan body in the ventral posterolateral nucleus of the human thalamus in relation to aging. Acta Neuropathol. (Berl.). 74:1987;9-12.
30. Mrak R.E., Sheng J.G., Griffin W.S.T. Correlation of astrocytic S100β expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:1996;273-279.
31. Robertson N.P., Wharton S., Anderson J., Scolding N.J. Adult polyglucosan body disease associated with an extrapyramidal syndrome. J. Neurol. Neurosurg. Psychiatry. 65:1998;788-790.
32. Robitaille Y., Carpenter S., Karpati G., DiMauro S. A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes. Brain. 103:1980;315-336.
33. Sakai M., Austin J., Witmer F., Trueb L. Studies of corpora amylacea: I. Isolation and preliminary characterization by chemical and histochemical techniques. Arch. Neurol. 21:1969;526-544.
34. Sbarbati A., Carner M., Colletti V., Osculati F. Extrusion of corpora amylacea from the marginal glia at the vestibular root entry zone. J. Neuropathol. Exp. Neurol. 55:1996;196-201.
35. Schäfer B.W., Heizmann C.W. The S100 family of EF-hand calcium-binding proteins: functions and pathology. TIBS. 21:1996;134-140.
36. Schipper H.M., Cisse S. Mitochondrial constituents of corpora amylacea and autofluorescent astrocytic inclusions in senescent human brain. Glia. 14:1995;55-64.
37. Schipper H.M., Cisse S., stopa E.G. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann. Neurol. 37:1995;758-769.
38. Schröder J.M., May R., Shin Y.S., Sigmund M., Nase-Hüppmeier S. Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis). Acta Neuropathol. 85:1993;419-430.
39. Singhrao S.K., Morgan B.P., Neal J.W., Newman G.R. Functional role for corpora amylacea based on evidence from complement studies. Neurodegeneration. 4:1995;335-345.
40. Singhrao S.K., Neal J.W., Piddlesden S.J., Newman G.R. New immunocytochemical evidence for a neuronal/oligodendroglial origin for corpora amylacea. Neuropathol. Appl. Neurobiol. 20:1994;66-73.
41. Stam F.C., Roukema P.A. Histochemical and biochemical aspects of corpora amylacea. Acta Neuropathol. (Berl.). 25:1973;95-102.
42. Steyaert A., Cissé S., Merhi Y., Kalbakji A., Reid N., Gauvreau D., Lacoste-Royal G. Purification and polypeptide composition of corpora amylacea from aged brain. J. Neurosci. Methods. 31:1990;59-64.
43. Tate-Ostroff B., Majocha R.E., Marotta C.A. Identification of cellular and extracellular sites of amyloid precursor protein extracytoplasmic domain in normal and Alzheimer disease brains. Proc. Natl. Acad. Sci. USA. 86:1989;745-749.
44. Tokutake S., Nagase H., Morisaki S., Oyanagi S. X-ray microprobe analysis of corpora amylacea. Neuropathol. Appl. Neurobiol. 21:1995;269-273.
45. Vogl T., Pröpper C., Hartmann M., Strey A., Strupat K., van den Bos C., Sorg C., Roth J. S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14. J. Biol. Chem. 274:1999;25291-25296.